Anti-BAG3/ BAG-3/ BIS monoclonal antibody

Anti-BAG3/ BAG-3/ BIS antibody for FACS & in-vivo assay

Target products collectionGo to BAG3/BAG3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2014-Ab-1/ GM-Tg-hg-MP2014-Ab-2Anti-Human BAG3 monoclonal antibodyHuman
GM-Tg-rg-MP2014-Ab-1/ GM-Tg-rg-MP2014-Ab-2Anti-Rat BAG3 monoclonal antibodyRat
GM-Tg-mg-MP2014-Ab-1/ GM-Tg-mg-MP2014-Ab-2Anti-Mouse BAG3 monoclonal antibodyMouse
GM-Tg-cynog-MP2014-Ab-1/ GM-Tg-cynog-MP2014-Ab-2Anti-Cynomolgus/ Rhesus macaque BAG3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2014-Ab-1/ GM-Tg-felg-MP2014-Ab-2Anti-Feline BAG3 monoclonal antibodyFeline
GM-Tg-cang-MP2014-Ab-1/ GM-Tg-cang-MP2014-Ab-2Anti-Canine BAG3 monoclonal antibodyCanine
GM-Tg-bovg-MP2014-Ab-1/ GM-Tg-bovg-MP2014-Ab-2Anti-Bovine BAG3 monoclonal antibodyBovine
GM-Tg-equg-MP2014-Ab-1/ GM-Tg-equg-MP2014-Ab-2Anti-Equine BAG3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2014-Ab-1/ GM-Tg-hg-MP2014-Ab-2; GM-Tg-rg-MP2014-Ab-1/ GM-Tg-rg-MP2014-Ab-2;
GM-Tg-mg-MP2014-Ab-1/ GM-Tg-mg-MP2014-Ab-2; GM-Tg-cynog-MP2014-Ab-1/ GM-Tg-cynog-MP2014-Ab-2;
GM-Tg-felg-MP2014-Ab-1/ GM-Tg-felg-MP2014-Ab-2; GM-Tg-cang-MP2014-Ab-1/ GM-Tg-cang-MP2014-Ab-2;
GM-Tg-bovg-MP2014-Ab-1/ GM-Tg-bovg-MP2014-Ab-2; GM-Tg-equg-MP2014-Ab-1/ GM-Tg-equg-MP2014-Ab-2
Products NameAnti-BAG3 monoclonal antibody
Formatmab
Target NameBAG3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BAG3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BAG3/ BAG-3/ BIS VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000662human BAG3 Lentivirus particle
    ORF Viral VectorpGMLP000662human BAG3 Lentivirus plasmid
    ORF Viral VectorpGMAD000523Norway rat Bag3 Adenovirus plasmid
    ORF Viral VectorvGMAD000523Norway rat Bag3 Adenovirus particle


    Target information

    Target IDGM-MP2014
    Target NameBAG3
    Gene ID9531,29810,293524,714420,486916,101094211,782633,100065784
    Gene Symbol and SynonymsBAG-3,BAG3,BIS,CAIR-1,MFM6,mg638
    Uniprot AccessionO95817
    Uniprot Entry NameBAG3_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000151929
    Target ClassificationTumor-associated antigen (TAA)

    The target: BAG3, gene name: BAG3, also named as BAG-3, BIS, CAIR-1, MFM6. BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The protein encoded by this gene contains a WW domain in the N-terminal region and a BAG domain in the C-terminal region. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.